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Introduction
For over 40 years I have enjoyed working collaboratively
on research projects to increase understanding of popula-
tion health with the aim of ultimately improving quality of
life. For almost 30 years I have been part of the study team
responsible for the MRC National Survey of Health and
Development (NSHD), the oldest of the British birth cohort
studies; and for the last 10 years have had the privilege of
being the NSHD director. Such a long-term study depends
on a committed and scientifically productive study team
which maintains study member engagement and attracts
expert scientific collaborators. For the last 20 years, I have
collaborated with Professor Yoav Ben-Shlomo and others
to develop the field of life course epidemiology, the study
of the long term effects of social and biological exposures
and experiences across life on later life health. So at the
outset, I acknowledge that this personal opinion piece
which I was invited to submit has implicitly and explicitly
been influenced by many colleagues. It also should be read
in conjunction with an accompanying article in this issue
on the recent 24th follow-up of the NSHD at the age of
70 years (Kuh et al., this issue) and a recent updated review
of life course epidemiology [1].
Background
I first recognised the degree of heterogeneity in the health
of older people and pondered its origins in 1974–1975
when delivering meals on wheels to a group of older people
in the US state of Vermont as part of the Federal Council
on Aging programme. What lifetime experiences had
enabled one 85 year old to remain sufficiently robust to
tend his few acres while another, at least a decade younger
but already frail, lived in squalid surroundings in a run-
down local boarding house? On returning to the UK, my
interest in life course ideas—how experiences earlier in life
can shape health and other life chances—was sparked by
two informative experiences in my early career. During my
first UK position as an operational research scientist for the
Department of Health in an outpost at Exeter University
(1975–1981), I helped to build computer models to inform
the resource allocation of health and social care expendi-
ture to different client or patient groups. The lack of dis-
cussion about the quality of care and its impact on people’s
lives was frustrating. One of my first research tasks was to
interview the nursing staff of an old hospital for adults with
mental and behavioural impairments about the abilities of
the inpatients on each ward, and whether they were seen as
suitable (or not) for community care. There were pho-
tographs of the patients before admission in their files,
many as young people, and hearing about their reasons for
admission and parts of their life stories, gave me a glimpse
of the lifelong impact on individuals of their environment.
So I was attracted by a job offer from one of the first
paediatricians in the NHS, Professor Frederic Brimble-
combe, an inspirational clinician who knew the value of
integrated and high quality holistic care services for chil-
dren with disabilities [2]. He asked me and a paediatric
registrar to run a research project (1982–1987) that
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involved interviewing 400 young people with physical and
mental disabilities about their unmet health and social
needs after they left paediatric care, and then making a case
for changes to local services to meet those needs. Hearing
about the factors that had shaped these young people’s
lives, their lack of opportunities, the impact of the social
and care environment and how public services could make
a difference left a deep impression.
By chance, a factor of considerable importance in
shaping lives [3], I met Professor Michael Wadsworth, then
the NSHD director, who told me how Dr James Douglas, a
physician with an interest in social medicine, had started
this birth cohort study in March 1946, following up 5362
babies born in one week that month in England, Scotland
and Wales. Wadsworth and others have captured the first
40 years of NSHD history elsewhere [4–6]. Some of the
key findings relate to: the social inequalities in infant
health and survival, and childhood educational opportunity
and attainment, even of children with high measured cog-
nitive ability; the power of parental interest for the child’s
education independently of school and family background;
the increased risk of adolescent behaviour problems in
those who experienced long or repeated hospital admis-
sions in early life, and the disruptive effects for the child of
parental divorce and separation.
I took up a post in the NSHD team in 1987, soon after
Wadsworth had moved the team to UCL. Wadsworth had
kept this birth cohort study alive against the odds in the late
1970s and early 1980s after Douglas retired [7]. The MRC,
who had started funding NSHD in 1962, agreed in 1981 to
give the study a 5-year reprieve to assess its benefits in
understanding the development of mental and physical ill-
health and its change in young adults, including continuous
measures of blood pressure and respiratory function. With
new data collected at 36 years, Wadsworth showed that
babies of low birthweight had higher adult blood pressure
[8]. On publication of this paper in the BMJ, he received a
phone call from the late Professor David Barker to say how
he had just beaten him in the publication of similar data.
This was to mark the end of a period of relative famine in
cohort investment in the UK. The late 1980s and 1990s was
an opportune time to arrive in the world of cohort studies
and chronic disease epidemiology. Barker’s imaginative
research using historical cohorts, and his fetal origins
hypothesis attracted a lot of attention, stimulated a new
research agenda, and was a catalyst in the revival of a life
course perspective in epidemiology. Visiting Barker to
discuss a collaborative paper was a high point of my first
year on the NSHD team; this paper [9] remains one of my
most highly cited, and the discussion we had that day
inspired me to focus my PhD thesis on testing the Barker
hypothesis in NSHD. The proliferation of papers and books
from Barker and his team stimulated a group of young
epidemiologists, many of whom were critical of Barker’s
methods and questioned his interpretation of the data, to:
review the literature on pre-adult risk factors associated
with cardiovascular and respiratory diseases, diabetes and
cancers; explore the social and biological pathways
between early life and adult disease; and consider the les-
sons to be learnt from time trends, geography and migra-
tion, and socioeconomic differentials. With Yoav Ben-
Shlomo, I took the opportunity to turn these reviews into
the first textbook on a life course approach to chronic
disease epidemiology [10]. The emergence of the field of
life course epidemiology which this book fostered had, for
me, a synergistic relationship with the direction of NSHD
research over the subsequent decades, each influencing the
other.
The NSHD in its 4th, 5th and 6th decades
This new scientific agenda on the early origins of adult
disease required investment in birth cohorts and revitalised
historical cohort studies as they provided the empirical
evidence to generate and test emerging developmental and
life course hypotheses. Between 1982 (when NSHD par-
ticipants were age 36) and 2006 (at age 60), Wadsworth
directed the NSHD with the aim of studying pathways to
physical and cognitive ageing with a particular focus on the
influence of early life factors. Home visits by research
nurses, first initiated at the 36 years follow-up, were used
again at ages 43 and 53 years, the core set of functional
assessments was expanded and the first blood sample col-
lected. In addition, we initiated a study of women’s midlife
health, by sending regular postal questionnaires from 47 to
57 years to women study members to capture the meno-
pause transition and changes in their midlife health. High
participation rates of over 80% were maintained at all these
follow-ups, helped by birthday cards and regular feedback
to study members, and by responding personally to those
with queries and those who shared additional life
experiences.
In brief, we used these data to demonstrate a large range
of associations between the early environment, physical,
cognitive and emotional development and functional age-
ing and age-related diseases in midlife, focusing on car-
diovascular, musculoskeletal, respiratory and mental
health, cognitive function and women’s reproductive
health. This research is summarised elsewhere [11], and
references to all publications are on the study website
(www.nshd.mrc.ac.uk). The NSHD research I led during
this period explored the developmental and early environ-
mental origins of musculoskeletal and reproductive ageing,
and of premature mortality. In brief, spurred on by my prior
interest in disability, and my collaborators’ interests in
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musculoskeletal function, baseline measures of grip
strength, standing balance and chair rise time were intro-
duced at the home visit at 53 years [12]. We were able to
show how the early social environment, patterns of child-
hood growth and neurodevelopmental measures were
related to these functional measures 40–50 years later, over
and above the effects of adult health and lifestyle [13–17].
In terms of women’s health, we found that developmental
factors, such as being breast fed, infant weight gain, and
higher childhood cognitive ability were associated with a
later onset of menopause whereas adverse early socioeco-
nomic circumstances (father’s social class, parental
divorce) were associated with an earlier onset, independent
of adult risk factors of nulliparity and smoking [18–22].
We also published a series of papers about lifetime factors
associated with premature mortality, focusing initially on
early factors, such as father’s social class, parental educa-
tion and childhood cognitive ability [23–28]. By age 53,
NSHD already had repeat measures of adult cardiovascular
and cognitive function so studies of functional change were
possible by others in the team (for example [29–31])
The key public health message from the team’s publica-
tions was that childhood mattered for adult health, and that
investment in the health and early environment of children
would lay the foundations for adult health. At that time,
evidence of the long-term impact on health and life chances
of early interventions in the US was being published [32].
During this period, parallel with the NSHD research, I
worked with others to develop conceptual frameworks,
models and methods for life course epidemiology and
apply them to a growing number of health outcomes,
modelling trajectories of risk (e.g. growth trajectories) and
increasingly studying functional trajectories or preclinical
traits that enabled the study of lifelong health before
chronic diseases were manifest [33–35].
The NSHD in its 7th decade
In 2007, I was appointed Director of the NSHD, and with a
remit to establish the MRC Unit of Lifelong Health in
Ageing and to transform the NSHD into a world class,
interdisciplinary study of ageing. Population ageing was
firmly on the political [36], social and research agendas in
the UK, as it was in other countries. There was and still is a
great pressure in the wider society to understand better the
social and biomedical factors that either accelerate or slow
down the rate of ageing. Within life course epidemiology,
there was also a growing focus on ageing, the progressive
decline in function, as this was a natural extension of
investigating functional trajectories. There was, and still is,
a lack of consensus on the definition of healthy ageing [37],
so we applied a pragmatic definition to help frame the
Unit’s thinking [38]. Healthy biological ageing was rep-
resented by survival to old age, delay in the onset of
chronic disease and optimal functioning for the maximum
period of time at the individual level (which we termed
physical and cognitive capability), and the underlying body
systems on which capability depended. Social and psy-
chological wellbeing, while important for healthy ageing,
did not necessarily decline with age, and was studied
separately, facilitating studies of bidirectional relation-
ships, concordance and discordance between healthy bio-
logical ageing and wellbeing.
During these 10 years, the team has undertaken two
major data collections, authored 500 publications,
increased the international and media profile of NSHD,
transformed the original card based metadata records into a
series of 21st century web-based data discovery, sharing
and governance tools, and instigated transparent data
sharing policies and procedures to support the huge
increase in data sharing. We have become an international
centre for life course epidemiology, inter-cohort studies,
and training and capacity building.
The NSHD follow-up at 60–64 years
Our pragmatic definition of healthy ageing informed a
pioneering new model of data collection for the NSHD.
Between ages 60 and 64, we asked study members who live
in England, Scotland and Wales, to attend one of six
clinical research facilities or to have a research nurse visit
them at home [39]. Working with expert collaborators,
clinic attendance allowed us to use imaging techniques to
obtain information on the structure and function of the
heart and blood vessels, and on body composition (using
DXA and pQCT), collect more biological samples, and
repeat our core measures of physical and cognitive capa-
bility and mental health. Study members responded posi-
tively to this request and we achieved an 84% overall
participation rate [40].
With these data, we showed, for example, the effects of
childhood and adult risk factors on bone, lean and fat mass
[41–48], on cardiac and vascular structure and function
[49–51], and on functional change [52–54]. Variation in
midlife physical and cognitive capability was meaningful in
terms of later mortality risk [55, 56]. These data also allowed
a more detailed assessment of fifteen common clinical dis-
orders where there is UK consensus about monitoring and
treatment by a GP or other clinician [57]. On average, par-
ticipants had two or more clinical disorders as they reached
retirement age, with less than one in six having none; and we
continue to show the early life origins of many of these
disorders [58–60], and their underlying risk factors [61, 62].
This period also saw a great increase in cross cohort
studies, some initiated by the team and others to which we
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contributed. Under the Healthy Ageing Across the Life
Course (HALCyon) collaborative programme, we brought
together NSHD with eight other UK cohort studies to
investigate the lifetime determinants of healthy ageing.
Here we undertook systematic reviews, meta-analyses and
cross cohort studies, complemented by in depth studies of
single cohorts, to gather evidence about the extent to which
early growth and later body size, childhood cognitive
ability and the early environment, and aspects of the
underlying biology (cortisol, telomeres and genetics) were
associated with one or more of our measures of physical
and cognitive capability or psychological and social
wellbeing.
We brought the results of over fifty HALCyon publi-
cations (see www.halycon.ac.uk), and a review of the lit-
erature, including the team’s own research, together in a
book on ‘A life course approach to healthy ageing’ [63]. In
brief, we found that healthy biological ageing was affected
by the same type of lifetime protective factors that reduced
the risk of chronic disease: less socioeconomic adversity,
no evidence of poor growth and development, maintenance
of normal weight across adult life, good prior health and
positive health behaviours. In contrast, wellbeing was less
affected by lifetime socioeconomic circumstances and
more affected by healthy relationships in childhood and
adult life. One of our conclusions was that there should be
more monitoring of risks and functional decline longitu-
dinally, at least from midlife, to identify groups at risk of
accelerated ageing who could benefit from timely inter-
ventions that could slow down ageing and promote phys-
iological resilience, or promote social and psychological
resilience in the face of accelerated functional ageing.
Cross cohort research was also expanded by setting up
the NSHD DNA resource and samples bank in 2008 (under
the careful leadership of Dr Andrew Wong). This enabled
the use of NSHD data in many more consortia investigating
the genetics of common diseases or traits and in Mendelian
Randomisation studies of the environmental determinants
of disease. We led or played a greater role in studies that
showed how genetic associations with body composition or
other health-related characteristics varied across life, acted
on the tempo of growth in childhood or were associated
with susceptibility to adult obesity [64–67]. Additional
funding and expert collaborators have also enabled the first
NSHD studies in epigenetics; and recent investments in
‘omic capabilities are currently facilitating new epigenetic
and metabolomic studies of functional ageing.
The NSHD follow-up at 68–69 years
The most recent data collection (a postal questionnaire in
2014 followed by a research nurse home visit in
2015–2016) took place at 68–69 years and high
participation rates were maintained (Kuh et al. this issue).
The first aim of this collection was to repeat our core
measures of physical and cognitive capability in order to:
(1) to look back and see whether relationships with earlier
life factors were persistent, and which lifetime factors were
associated with functional change; (2) to look forward to
see whether midlife capability and any subsequent change
were related to morbidity, disability and quality of life; and
(3) whether they related to ageing at the body system,
cellular and molecular levels.
The second aim of the data collection was to capture
morbidity and multi-morbidity in more detail than before in
order to: (1) to investigate their relationships with age-
related disease, reduced physical and cognitive capability,
and earlier life social and biomedical factors; and (2) to
show how all these aspects of health jointly impaired
wellbeing, quality of life and risk autonomy and indepen-
dence at older ages. At this visit, we repeated our core
mental health and wellbeing measures, introduced stan-
dardised scales to capture chronic pain [68], fatigability,
sleep quality, incontinence and mental status, and collected
more detail than before on functional limitations, activities
of daily living, instrumental activities of daily living, the
use of health and social services, and social participation.
These new data are just becoming available and many
studies that extend the team’s previous research are
ongoing. For example, we have already found that adding
repeat measures of fluid cognition at age 69 to our three
previous adult measures since age 43 are changing the
shape of the cognitive trajectories and identifying certain
groups with accelerated decline. We are developing
approaches to study psychological and social resilience in
older people [69, 70], for example those with high well-
being despite functional decline. We are also developing
approaches to study lifetime pathways to multi-morbidity,
preliminary analyses having shown that over one in five
now have three or more doctor diagnosed conditions (out
of a possible 19), and that 29% women and 15% of men
report three or more common conditions (chronic pain,
fatigability, poor sleep quality, incontinence and falls).
The neuroscience clinical sub-study 69–73 years
Having successfully brought study members into clinics to
image the cardiovascular and musculoskeletal systems at
60–64 years, we are now collaborating with colleagues at the
Institute of Neurology on an ambitious neuroscience sub-
study in NSHD, called Insight 46 which has secured addi-
tional funding. It requires participants from across mainland
Britain to travel and stay overnight in London, consent to a
PET scan requiring the use of a tracer, and to a battery of
neuropsychological tests and biological samples during a day-
long session at the clinic, and be willing to repeat this
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assessment in 2 years. The main aims are to discover the
genetic and life course influences on the development of
Alzheimer’s pathology, neurodegeneration and cognitive
decline; explore the earliest biomarker and imaging changes
inAlzheimer’s disease; validate sensitivemeasures of disease
progression; and use these data to optimise trial design for
clinical trials aiming to prevent Alzheimer’s disease. An
Insight 46 protocol paper is forthcoming.
Study member engagement and participation
To what extent cohort studies need to have high partici-
pation rates or be representative of the general population
is a matter of much debate and depends on the purpose of
the study [71, 72]. The NSHD study team uses various
strategies to maintain its high participation rate as this
helps to minimise bias [73, 74], and supports descriptive
epidemiology to inform evidence-based healthcare plan-
ning [75].While attrition is least amongst more advantaged
socioeconomic groups and those with higher cognitive
function [40], we still maintain a sufficiently high pro-
portion of those from more deprived backgrounds or with
lower function to test many life course hypotheses.
In the last 10 years, we have asked more of study
members: decreasing the time between data collections
which have consisted of both postal questionnaires and
visits, including travel to clinics, and more clinical
assessments and biological samples. This posed a risk to
participation, especially as other studies have shown that
permanent withdrawal and non-participation become more
common with advancing age [76], and in general partici-
pation is falling in many epidemiological studies [77]. The
study team have extended the ways in which they try to
maintain participation rates of at least 80%: by being ever
more diligent in responding to individual queries and
comments, ensuring the experience of taking part is as
smooth as possible and providing ever more tailored
information and feedback; and by creating an even greater
sense of identity with the study by requesting study
members’ personal experiences of being in the study,
providing opportunities to meet other participants and the
team through events held to mark the 65th and 70th
birthdays, and working with them to increase the study’s
public profile. The stories of NSHD study members can be
listened to on our website (http://nshd.mrc.ac.uk/70thbirth
day/birthdayevents/afternoon-talks/).
The NSHD 70th birthday party in London, March 2016
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Despite our concerns, the overall participation rate reached
94% at the latest data collection, and we now have some
evidence that these extra efforts increased participation,
even allowing for the history of past contact (Kuh et al. this
issue). We will use this evidence to design the best ways to
continue high participation into the 8th decade.
The neuroscience sub-study is the most demanding
request we have ever made to study members. The Insight
46 team works closely with participants to fully explain the
undertaking and the participants’ willingness to be
involved is testament to this type of approach; to date over
250 study members have taken part in this sub-study.
Current and future challenges for NSHD and life
course epidemiology
Developing NSHD’s scientific niche
All prospective cohort studies must find and continually
evolve their scientific niche to be successful. The NSHD has
survived for 70 years through an ever changing research
landscape. Now, in the world of biobanks and very large
cohort studies, the rise of data intensive biology, data link-
age, and the promise of precision medicine [78, 79],
NSHD’s scientific niche needs to be re-evaluated and re-
affirmed, at a time when MRC, ESRC and Wellcome Trust
are carrying out their own reviews of longitudinal resources
ahead of a major shift in the structure of the UK research
councils following a review by Sir Paul Nurse for the UK
government on how these research councils could support
UK science most effectively [80]. In this context, the team
will need to show how innovative science that integrates big
data with the rich prospective data archives from NSHD and
other cohort studies adds scientific value. The NSHD and
other life course studies with repeat measures in childhood
and adult life, will continue to complement large new
cohorts such as UK Biobank for many years. They can
investigate how changing social and biological exposures
across childhood and young adulthood, as well as during
adult life, influence level and change in health outcomes, and
whether later life factors are modified by those in early life.
So far, output from UK Biobank has replicated some of the
links between development and ageing first demonstrated in
the smaller studies, using retrospective data albeit on a much
larger sample (for example see [81, 82]) Over time, as novel
or more finely grained adult phenotypic characteristics are
discovered in these very large cohorts to be risk factors for
subsequent disease, life course studies will be able to iden-
tify their early drivers.
Biomedical scientific knowledge is growing rapidly and
can support a strong case for continuing NSHD until the
expected 300 participants become centenarians, even in the
more austere world that cohort studies are now operating
in. The future scientific vision for NSHD in its 8th decade
will be for the next Director to develop with the team.
Developing dynamic concepts of health and ageing,
redefining disease
The life course research undertaken on NSHD and other
cohort studies, and the concepts and ideas of life course
epidemiology have played their part in helping to widen the
study of health and ageing beyond a traditional epidemio-
logical focus on specific age-related diseases. The value of
studying lifelong health through measures of function,
capturing how function changes with age across life, and its
lifetime drivers and consequences, is now widely
acknowledged. While the UK came later than many other
countries, such as the US, in recognising mobility and
cognition as hallmarks of ageing, the wealth of birth cohort
data in this country has meant we have been able to add a life
course epidemiological perspective to this research area.
The NSHD 70th birthday party in Manchester, March 2016
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A broad, interdisciplinary research effort is underway
investigating biomarkers of ageing both for aetiological
insights of underlying biological pathways, and to test
whether quantitative biomarker profiles predict age-related
functional change or disease development. A current
challenge for epidemiologists and cohort investigators is to
work with biologists and other scientists to exploit these
intensive data at the cellular and molecular level in ways
that will help to redefine disease, identify common ageing
mechanisms, and offer opportunities for precision medicine
[83]. Rapidly developing technologies allow these data to
be collected on large samples and, over time, high
throughput allows costs to diminish. A challenge is to
apply a life course perspective in this world of ‘omics and
geroscience, to the hallmarks of ageing at the body systems
[84], and molecular levels [85]; thus increasing scientific
knowledge of the mechanisms underlying the develop-
mental and early environmental origins of ageing. Life
course epidemiology also needs to remain true to its roots
by finding novel ways to incorporate social and cultural
change across cohorts with big data on biology and the
exposome. Reports on precision medicine allude to the
importance of socioeconomic factors ([83] p. 43–44), but
interest in social epidemiology, social medicine, and social
inequalities has dropped down the research as well as the
political agenda. As Brayne argues in a recent editorial,
long running cohort studies should be wary of ‘attaching to
the coat tails of the latest cutting edge cellular, molecular
and imaging technologies,’ and maintain their wider per-
spective on the major challenges of human society [86].
Many years ago, Dubos recognised that health and dis-
ease reflect the ability of an organism to adapt to envi-
ronmental challenges [87]. New biological and technical
developments provide opportunities to study physiological
resilience in more depth, in addition to the studies of
psychological and social resilience which are becoming
more prevalent at older ages [69]. Here, concepts and
methods for studying resilience from a life course per-
spective need to be further developed and tested. There is
still much to explore about the extent of continuity in
resilience across life, or whether there are later health costs
of early resilience. Increasing research on how individuals
respond to environmental challenges will promote a more
dynamic concept of general health based on physiological,
psychological and social adaptations [88]. It encourages the
collection of dynamic assessments of health and function
(e.g. changes in mood, blood pressure variability), and the
long-term impact of individual variability or acute events
(such as acute illnesses).
Capacity building
The deepening and widening cohort data archives through
the addition of big data and record linkage, and the increase
in data sharing and cross cohort collaborations is shifting
the balance between primary and secondary data users in
favour of the latter. These changes make it harder for early
career scientists to make their mark, and be recognised for
their contribution [89]; and it means that many may never
be involved in collecting primary data. Training in popu-
lation sciences needs to ensure that the next generation
develop into innovative researchers who can think cre-
atively, conceptually and rigorously about complex prob-
lems [90], assess the quality of data for themselves, know
when (and when not) to apply increasingly complex sta-
tistical models, and how to collaborate effectively. Study
teams running long-term cohorts need to offer opportuni-
ties for career development to attract some of the most able
to be the next generation of primary investigators.
Does life course epidemiology matter?
The life course approach has been incorporated into many
policy documents about lifelong health and ageing (see
examples in Box 1). In that sense, the field matters,
although as I have discussed elsewhere [91], there are
substantial challenges of translating research findings from
observational studies, and life course studies in particular,
into practice or policy-relevant messages for healthy age-
ing or for other health outcomes. Scientists, including
myself, using data from NSHD and other life course studies
have been primarily concerned with knowledge creation
Box 1 Examples of the life course perspective in recent policy documents on lifelong health and ageing
‘‘The evidence base for the life course approach is strong. What happens early in life (indeed in fetal life) affects health and wellbeing in later
life’’ [96]
The… diversity in the capacities and health needs of older people is not random, but rooted in events throughout the life course that can often be
modified, underscoring the importance of a life course approach’’ [97]
‘‘Fostering healthy ageing will require a much better understanding of common trajectories of intrinsic capacity and functional ability, their
determinants and the effectiveness of interventions to modify them’’ [97]
‘‘Transforming services for older people requires a fundamental shift towards care that is co-ordinated around the full range of an individual’s
needs (rather than care based around single diseases)’’ [98]
‘‘Successful policy responses in an ageing population are likely to be those which take a whole life course approach’’ [99]
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and dissemination [92], albeit including the policy impli-
cations of the findings. As researchers, we face a tension
between being cautious in extrapolating our findings, and
the growing demands of research funders and policy
makers to demonstrate impact. Life course epidemiology
will contribute to and benefit from the wider debate within
epidemiology about study designs and analytical strategies
for going beyond associations between exposures and
outcomes to explanations based on a pluralistic approach to
causal inference [93, 94]. This should strengthen recom-
mendations for policy and interventions by ensuring they
are based on the best evidence.
The impact of the findings from cohort studies such as
NSHD and from life course epidemiology has often been
indirect through their influence on popular thinking. I agree
with Keyes [95] who suggests that life course epidemiol-
ogy has broadened our understanding of factors that
underlie health and illness, and is part of the epidemiology
of consequence that focuses on ‘what matters most for
population health’ which include the ‘early life, upstream,
and macro policy-related factors that are the critical drivers
of many adult outcomes’ (p. 8). However, the implications
from life course research, for example, about the long-term
effects of early adversity for population ageing may not be
attractive in the current political climate [1].
Conclusions
Just as an individual must adapt to ever changing environ-
mental challenges for a long and healthy life, researchers
responsible for a birth cohort study must adapt to ever
changing scientific knowledge and research environments.
The study team must engage participants and address
questions of scientific and policy relevance at each life stage
to have a chance of becoming a cradle to grave study. It has
been my privilege to serve the NSHD for 30 years, and to
have led the study and the study team for 10 years. I
acknowledge the strong team I have worked with and thank
the participants who, being just 7 years older, have shown
me at each stage of adult life what might lie ahead in my own
life trajectory. Findings from this study were originally used
to help design services for pregnant women, mothers and
young children when the National Health Service (NHS)
was established in 1948. Findings from this study are
increasingly being used to improve services for older people
at a critical time in the history of the NHS and social care.
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